IBDEI0SY ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13027,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,13027,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,13028,0)
 ;;=H10.31^^51^627^14
 ;;^UTILITY(U,$J,358.3,13028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13028,1,3,0)
 ;;=3^Conjunctivitis,Acute,Rt Eye
 ;;^UTILITY(U,$J,358.3,13028,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,13028,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,13029,0)
 ;;=H02.829^^51^627^15
 ;;^UTILITY(U,$J,358.3,13029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13029,1,3,0)
 ;;=3^Cysts,Unspec Eyelid
 ;;^UTILITY(U,$J,358.3,13029,1,4,0)
 ;;=4^H02.829
 ;;^UTILITY(U,$J,358.3,13029,2)
 ;;=^5133442
 ;;^UTILITY(U,$J,358.3,13030,0)
 ;;=H02.834^^51^627^21
 ;;^UTILITY(U,$J,358.3,13030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13030,1,3,0)
 ;;=3^Dermatochalasis,Lt Upper Eyelid
 ;;^UTILITY(U,$J,358.3,13030,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,13030,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,13031,0)
 ;;=H02.831^^51^627^22
 ;;^UTILITY(U,$J,358.3,13031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13031,1,3,0)
 ;;=3^Dermatochalasis,Rt Upper Eyelid
 ;;^UTILITY(U,$J,358.3,13031,1,4,0)
 ;;=4^H02.831
 ;;^UTILITY(U,$J,358.3,13031,2)
 ;;=^5004418
 ;;^UTILITY(U,$J,358.3,13032,0)
 ;;=H04.123^^51^627^23
 ;;^UTILITY(U,$J,358.3,13032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13032,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,13032,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,13032,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,13033,0)
 ;;=H02.135^^51^627^24
 ;;^UTILITY(U,$J,358.3,13033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13033,1,3,0)
 ;;=3^Ectropion,Senile,Lt Lower Eyelid
 ;;^UTILITY(U,$J,358.3,13033,1,4,0)
 ;;=4^H02.135
 ;;^UTILITY(U,$J,358.3,13033,2)
 ;;=^5133414
 ;;^UTILITY(U,$J,358.3,13034,0)
 ;;=H02.132^^51^627^25
 ;;^UTILITY(U,$J,358.3,13034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13034,1,3,0)
 ;;=3^Ectropion,Senile,Rt Lower Eyelid
 ;;^UTILITY(U,$J,358.3,13034,1,4,0)
 ;;=4^H02.132
 ;;^UTILITY(U,$J,358.3,13034,2)
 ;;=^5004318
 ;;^UTILITY(U,$J,358.3,13035,0)
 ;;=H35.3210^^51^627^30
 ;;^UTILITY(U,$J,358.3,13035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13035,1,3,0)
 ;;=3^Exudative AMD,Rt Eye
 ;;^UTILITY(U,$J,358.3,13035,1,4,0)
 ;;=4^H35.3210
 ;;^UTILITY(U,$J,358.3,13035,2)
 ;;=^5138520
 ;;^UTILITY(U,$J,358.3,13036,0)
 ;;=H35.3220^^51^627^29
 ;;^UTILITY(U,$J,358.3,13036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13036,1,3,0)
 ;;=3^Exudative AMD,Lt Eye
 ;;^UTILITY(U,$J,358.3,13036,1,4,0)
 ;;=4^H35.3220
 ;;^UTILITY(U,$J,358.3,13036,2)
 ;;=^5138524
 ;;^UTILITY(U,$J,358.3,13037,0)
 ;;=H20.00^^51^627^33
 ;;^UTILITY(U,$J,358.3,13037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13037,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,13037,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,13037,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,13038,0)
 ;;=H02.204^^51^627^34
 ;;^UTILITY(U,$J,358.3,13038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13038,1,3,0)
 ;;=3^Lagophthalmos,Unspec,Lt Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,13038,1,4,0)
 ;;=4^H02.204
 ;;^UTILITY(U,$J,358.3,13038,2)
 ;;=^5004330
 ;;^UTILITY(U,$J,358.3,13039,0)
 ;;=H02.201^^51^627^35
 ;;^UTILITY(U,$J,358.3,13039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13039,1,3,0)
 ;;=3^Lagophthalmos,Unspec,Rt Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,13039,1,4,0)
 ;;=4^H02.201
 ;;^UTILITY(U,$J,358.3,13039,2)
 ;;=^5004327
